UNITS PLUMMETS AFTER NOVO NORDISK DEAL COLLAPSE

Shares of HIMS experienced a dramatic decline today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending the company's stock price plummeting by more than 20%. The reason for the dissolution of the partnership remains unclear, but industry analysts specu